MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht - Downloaded Version 2027.0.0-ballot.1 See the Directory of published versions
{
"resourceType" : "ServiceRequest",
"id" : "mii-exa-molgen-anforderung-fgfr2-fusion",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"
]
},
"language" : "de",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: ServiceRequest mii-exa-molgen-anforderung-fgfr2-fusion</b></p><a name=\"de-mii-exa-molgen-anforderung-fgfr2-fusion\"> </a><a name=\"de-hcmii-exa-molgen-anforderung-fgfr2-fusion\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-molgen-anforderung-genetischer-test.html\">MII PR MolGen Anforderung genetischer Test</a> version: 2027.0.0-ballot.1</p></div><p><b>identifier</b>: <code>https://www.charite.de/fhir/auftragsnummern</code>/PRK4QE59A</p><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>category</b>: <span title=\"Codes:{http://snomed.info/sct 108252007}\">Laboratory procedure (procedure)</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 405825005}\">Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom</span></p><p><b>subject</b>: <a href=\"Patient-mii-exa-molgen-patient-fgfr2-fusion.html\">Anonymous Patient Female, DoB: 1964-05 ( pseudonymized\u00a0(use:\u00a0usual,\u00a0))</a></p><p><b>authoredOn</b>: 2022-11-30</p><p><b>requester</b>: <a href=\"Practitioner-mii-exa-molgen-practitioner-physician.html\">Practitioner Dr. Linda Rubens(official)</a></p><p><b>reasonCode</b>: <span title=\"Codes:{http://snomed.info/sct 109842005}, {http://fhir.de/CodeSystem/bfarm/icd-10-gm C22.1}\">Intrahepatic bile duct carcinoma (disorder)</span></p></div>"
},
"identifier" : [
{
"system" : "https://www.charite.de/fhir/auftragsnummern",
"value" : "PRK4QE59A"
}
],
"status" : "active",
"intent" : "order",
"category" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "108252007",
"display" : "Laboratory procedure (procedure)"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "405825005",
"display" : "Molecular genetic test (procedure)"
}
],
"text" : "Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"authoredOn" : "2022-11-30",
"requester" : {
🔗 "reference" : "Practitioner/mii-exa-molgen-practitioner-physician"
},
"reasonCode" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "109842005",
"display" : "Intrahepatic bile duct carcinoma (disorder)"
},
{
"system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
"version" : "2024",
"code" : "C22.1",
"display" : "Intrahepatisches Gallengangskarzinom"
}
]
}
]
}